Patterson Companies Competitors and Similar CompaniesClear all
Patterson Companies's competitors and similar companies include Takeda, Henry Schein, Vivesto and Aoxing Pharmaceutical.
 Patterson Companies Patterson Companies is a medical supplies company operating in the business of veterinary and dental products. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Henry Schein Henry Schein is a provider of healthcare products and services to dental and medical practitioners. |  Vivesto Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology. | ||
Founding Date | Founding Date 1877 | Founding Date 1781 | Founding Date 1932 | Founding Date 1990 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Mendota Heights, US HQ Denver, US Potomac, US Alachua, US Albuquerque, US Alexandria, US Amarillo, US see more | Locations Melville, US HQ Sydney, AU Vienna, AT Vilvoorde, BE Niagara On The Lake, CA Prague, CZ Paris, FR see more | Locations Uppsala, SE HQ Solna, SE | Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US | |
Employees | Employees 7,6001% decrease | Employees 47,4554% decrease | Employees 25,000 | Employees 4 | Employees 346 |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 43.7 b | Valuation ($) 8.9 b | Valuation ($) 13.6 m | Valuation ($) 5.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $6.6b (FY, 2024) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $13.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $32.3m (FY, 2016) |
Cost of goods | Cost of goods $5.2b (FY, 2024) | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $9.1b (FY, 2025) | Cost of goods N/A | Cost of goods $7.8m (FY, 2016) |
Gross profit | Gross profit $1.4b (FY, 2024) | Gross profit ¥3.8t (FY, 2025) | Gross profit $4.1b (FY, 2025) | Gross profit N/A | Gross profit $24.6m (FY, 2016) |
Net income | Net income $185.5m (FY, 2024) | Net income ¥108.1b (FY, 2025) | Net income $419m (FY, 2025) | Net income (kr34.1m) (FY, 2025) | Net income $2.1m (FY, 2016) |
Operating ⚠ | |||||
Customers | Customers 150 k (FY, 2022) | Customers N/A | Customers 1 m (FY, 2021) | Customers N/A | Customers N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 250m | Total funding raised $ 19.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyHenry Schein
HQ
Melville, US
Employees
25,000
Henry Schein is a provider of healthcare products and services to dental and medical practitioners.
View companyVivesto
HQ
Uppsala, SE
Employees
4
Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology.
View company
Aoxing Pharmaceutical
HQ
Shijiazhuang Shi, CN
Employees
346
Aoxing Pharmaceutical is a specialty pharmaceutical company.
View company